BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38600440)

  • 1. Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
    Routila E; Mahran R; Salminen S; Irjala H; Haapio E; Kytö E; Ventelä S; Petterson K; Routila J; Gidwani K; Leivo J
    BMC Cancer; 2024 Apr; 24(1):443. PubMed ID: 38600440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance.
    Ventelä S; Sittig E; Mannermaa L; Mäkelä JA; Kulmala J; Löyttyniemi E; Strauss L; Cárpen O; Toppari J; Grénman R; Westermarck J
    Oncotarget; 2015 Jan; 6(1):144-58. PubMed ID: 25474139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.
    Zhang MJ; Liu J; Wan SC; Li JX; Wang S; Fidele NB; Huang CF; Sun ZJ
    Head Neck; 2023 Sep; 45(9):2161-2172. PubMed ID: 37466293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
    Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
    Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
    Li Z; Wu X; Li J; Yu S; Ke X; Yan T; Zhu Y; Cheng J; Yang J
    Exp Cell Res; 2022 Sep; 418(1):113271. PubMed ID: 35764101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.
    Lu WC; Liu CJ; Tu HF; Chung YT; Yang CC; Kao SY; Chang KW; Lin SC
    Oncotarget; 2016 Aug; 7(35):57254-57267. PubMed ID: 27528032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
    Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.
    Routila J; Bilgen T; Saramäki O; Grénman R; Visakorpi T; Westermarck J; Ventelä S
    J Oral Pathol Med; 2016 May; 45(5):329-37. PubMed ID: 26436875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy.
    Ma H; Xiong L; Zhao B; Hahan Z; Wei M; Shi H; Yang S; Ren Q
    Front Immunol; 2024; 15():1364082. PubMed ID: 38562924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
    Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
    Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
    Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
    Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β Promotes Stemness of Tumor Cells by Activating Smad/ID1 Signaling Pathway.
    Lu L; Wang P; Zou Y; Zha Z; Huang H; Guan M; Wu Y; Liu G
    Int J Med Sci; 2020; 17(9):1257-1268. PubMed ID: 32547321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization].
    Zheng SZ; Meng L; Ren FL; Ren CX; Li X; Wang DD; Sun HC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):510-516. PubMed ID: 37248576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC.
    Kamarajan P; Shin JM; Qian X; Matte B; Zhu JY; Kapila YL
    Cancer Med; 2013 Dec; 2(6):793-802. PubMed ID: 24403253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.
    Ge L; Smail M; Meng W; Shyr Y; Ye F; Fan KH; Li X; Zhou HM; Bhowmick NA
    PLoS One; 2011; 6(11):e27529. PubMed ID: 22096589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
    Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
    Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.